Skip to content

iSert Intraocular Lens 250 (clear), +9.50DRecalls & reported problems

Hoya Medical Singapore Pte. Ltd. · Class 3 · Implant

All models of iSert Intraocular Lens (69)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04547480480572), received between Aug 9, 2021 and Aug 9, 2021 — classified as 1 injury.

The most frequently reported specific device problem is “Unexpected Therapeutic Results” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Unexpected Therapeutic Results1

Patient problems

  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryAug 9, 2021Unexpected Therapeutic Results; Unexpected Therapeutic Results

    IMPLANT DATE: (B)(6) 2021. ERROR OF PREDICTED REFRACTIVE; UNEXPECTEDLY LOW VISUAL ACUITY. SUSPECTED WRONG POWER LENS. PRODUCT REMAINED IN EYE AFTER CLINICAL ASSESSMENT.

    Patient problems: Visual Impairment

    MAUDE report 12294907 ↗

Other Intraocular Lens devices

All Intraocular Lens devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page